Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Researchers use combined approach to estimate the timing of first SARS-CoV-2 case

Researchers who simulated early stages of the SARS-CoV-2 outbreak in Wuhan, China, conclude that the virus was likely circulating earlier than has been described, possibly even in mid-October 2019.

19 Mar 2021

Mass vaccination needed to protect against future resurgences of COVID-19

The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had antibodies against COVID-19 in April 2020, and 82% of these people had an asymptomatic infection.

19 Mar 2021

“Crisis Response” is the motto of the 2021 Local Health Authority Day

Coping with the pandemic is a task for the society as a whole. In this connection, the around 400 municipal health authorities are a central pillar for the protection of public health in Germany.

19 Mar 2021

Study shows how ACE2 mutations influence SARS-CoV-2 spike binding in humans and animals

Researchers at the University of Wisconsin–Madison aimed to better understand how SARS-CoV-2 interacts with various mammalian angiotensin-converting enzyme 2 (ACE2) receptors. This way, they can identify the factors that influence intra- and cross-species virus transmission.

18 Mar 2021

Engineering immunogens to focus immune response to SARS-CoV-2

Researchers have designed constructs by adding more glycans and adding the receptor-binding motif from related sarbecoviruses to focus the immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding motif. Such immunogens could potentially also neutralize other variants and coronaviruses.

18 Mar 2021

Identifying druggable targets on an essential SARS-CoV-2 protein

In a research paper recently uploaded to the preprint server bioRxiv by Newman et al. (March 15th, 2021) the structure and role of one such protein: NSP13, is investigated, with two appealingly druggable targets being identified, possibly opening a new route towards a novel SARS-CoV-2 antiviral agent.

18 Mar 2021

Fighting SARS-CoV-2 with materials science

In a recent editorial in the journal Emergent Materials, Dr. Huseyin C. Yalcin from Qatar University Biomedical Research Center and Dr. Ajeet Kaushik from Florida Polytechnic University announce several important developments in their timely special issue entitled “Materials Science in the Battle against COVID-19”.

18 Mar 2021

UK SARS-CoV-2 variant 40% more transmissible than previous strains

Researchers in Japan have estimated that the B.1.1.7 strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that recently emerged in England is 40% more transmissible than strains previously circulating in the country.

18 Mar 2021

SARS-CoV-2 vaccination should be carefully targeted towards certain groups, say researchers

Researchers in the UK have provided important insights into the impact that vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – may have on infection rates, disease prevalence and immune escape by the virus.

18 Mar 2021

New study provides comparative analysis of twelve COVID-19 vaccines

A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage by early November 2020.

18 Mar 2021

Study highlights the importance of protecting elderly people from COVID-19 reinfection

Most people who have had COVID-19 are protected from catching it again for at least six months, but elderly patients are more prone to reinfection, according to research published in The Lancet.

18 Mar 2021

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

COVID-19 disproportionately affects men compared with women, raising the possibility that a hormone like progesterone may improve clinical outcomes for certain hospitalized men with the disease.

18 Mar 2021

Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation

Researchers at the Bio21 Institute and Department of Biochemistry and Pharmacology, The University of Melbourne, studied the structure of a SARS-CoV-2 spike receptor-binding domain (RBD) with a G485R mutation. This mutation is a residue and not directly involved in interactions with the angiotensin-converting enzyme 2 (ACE2) residues but found in the Β1´/Β2' loop region.

18 Mar 2021

New study maps SARS-CoV-2 and host protein interactions in detail

A new study has developed a systemic map detailing the mechanistic interactions and disruptions between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its host cell.

18 Mar 2021

SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion

A recent study found that the Pfizer-BioNTech mRNA vaccine had limited efficacy in identifying mutated receptor-binding domains (RBDs) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein similar to the B.1.351 and P.1 variants.

18 Mar 2021

Landmark Covid relief law pumps more than $100 billion into public health

Acknowledging that chronic underfunding of public health contributed significantly to the nation's fragmented response to the coronavirus pandemic, Democrats included more than $100 billion in the recently enacted relief package to address urgent needs and enhance future efforts.

18 Mar 2021

Study reveals unknown immune defense system that protects the lungs from viral infections

Researchers have uncovered a previously unknown arm of the immune defence system that protects the lung from lethal viral infections.

18 Mar 2021

How resistant is the SARS-CoV-2 Brazilian variant to antibodies?

Researchers based at the University of Oxford, UK, have shown that the P.1 Brazilian variant of SARS-CoV-2 is less resistant to natural or vaccine acquired antibody responses than the B.1.351, South African, variant, despite sharing convergent mutations.

18 Mar 2021

Can vaccine evading SARS-CoV-2 variants be restricted by prioritized vaccine rollout?

A new study discusses the question of how vaccine priority is affected by the possibility of vaccine escape.

18 Mar 2021

Could cinnamon modulate the immune response in severe COVID-19?

A new study describes the potential for two common plant products to make a difference in the management of severe COVID-19.

18 Mar 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Researchers use combined approach to estimate the timing of first SARS-CoV-2 case

Mass vaccination needed to protect against future resurgences of COVID-19

“Crisis Response” is the motto of the 2021 Local Health Authority Day

Study shows how ACE2 mutations influence SARS-CoV-2 spike binding in humans and animals

Engineering immunogens to focus immune response to SARS-CoV-2

Identifying druggable targets on an essential SARS-CoV-2 protein

Fighting SARS-CoV-2 with materials science

UK SARS-CoV-2 variant 40% more transmissible than previous strains

SARS-CoV-2 vaccination should be carefully targeted towards certain groups, say researchers

New study provides comparative analysis of twelve COVID-19 vaccines

Study highlights the importance of protecting elderly people from COVID-19 reinfection

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation

New study maps SARS-CoV-2 and host protein interactions in detail

SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion

Landmark Covid relief law pumps more than $100 billion into public health

Study reveals unknown immune defense system that protects the lungs from viral infections

How resistant is the SARS-CoV-2 Brazilian variant to antibodies?

Can vaccine evading SARS-CoV-2 variants be restricted by prioritized vaccine rollout?

Could cinnamon modulate the immune response in severe COVID-19?

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in